Rebalix
Amundi · sheet of 5 September 2026
Amundi · sheet of 5 September 2026ETF sheet · official issuer and register data
Amundi MSCI Emerging Markets Swap II UCITS ETF USD Acc
2820 · FR0010435297 · class USD Acc · USD · domicile France
Equity · GlobalSFDR art. 6
Index tracked: MSCI Emerging Markets Net Total Return USD Index
- TER
- 0.55%+ trans. 0.00%
- Fund size
- 39 m EUR
- Tracking difference
- −0.46%3-year avg
- 🇮🇹 tax rate
- 26.00%white list 0.00%
- Replication
- Synthetic (swap)
- Income
- Accumulating
Launch 5 Sept 2018 · costs from the KID as of 2 Sept 2026 · 29 securities held · 5 venues (ESMA register)
The fund’s objective — in the issuer’s words
From the Key Information Document (KID) · 7 Aug 2026
The Sub-fund is a passively managed index-based UCITS. The Sub-fund's objective is to replicate, both upwards and downwards, the performance of the MSCI Emerging Markets Net Total Return Index (net dividends reinvested) (the "Benchmark"), denominated in US dollars (USD) and representative of the performance of large- and mid-cap companies in all developed countries, while minimising the tracking error between the Fund's performance and that of the Benchmark. The expected level of the Tracking Error under normal market conditions is indicated in the Fund…
Performance since series start (in euro) — base 100
1 Oct 2012 → 3 Sept 2026 · dividends reinvested where declared by the issuer · converted at ECB rates
Returns in euro
| 1 year | +37.1% |
| 3 years | +70.3% |
| 5 years | +46.5% |
| 10 years | +117.9% |
| Since series start | +139.8% |
Risk · 1 / 3 / 5 years
| Volatility (ann.) | 22.98% | 17.80% | 17.51% |
| Max drawdown | −13.54% | −15.90% | −34.72% |
| Sharpe | 1.36 | 1.01 | 0.35 |
| Sortino | 2.04 | 1.45 | 0.50 |
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · 2820 · FR00104352971
Rebalix2820 · FR0010435297 · sheet of 5 September 2026
Tracking difference — year by year
Fund minus index, complete calendar years · from issuer-declared series
| Year | Fund | Index | TD |
|---|---|---|---|
| 2025 | +33.13% | +33.57% | −0.44% |
| 2024 | +7.08% | +7.50% | −0.42% |
| 2023 | +9.31% | +9.83% | −0.52% |
| 2022 | −20.42% | −20.09% | −0.33% |
| 2021 | −2.99% | −2.54% | −0.45% |
Holdings
Synthetic replication: top positions of the substitute basket (swap collateral), not the fund’s exposure · 1 Sept 2026 · 29 securities · top-10 weight = 55.4%
| Top holdings | Weight |
|---|---|
| 7.4% | |
| 6.8% | |
| 6.1% | |
| 6.0% | |
| 5.7% | |
| 5.4% | |
| 4.6% | |
| 4.6% | |
| 4.4% | |
| 4.4% |
Listing venues
ESMA register (FIRDS) and official exchange lists
LNY4 · Börse Düsseldorf, Börse Hamburg, Börse Hannover, Börse München / gettex, Tradegate Exchange
+ 6 unmapped venues (MTF, RFQ, professional)
Official documents
Clickable links in the PDF
The live sheet, always up to date
rebalix.com/en/etf/FR0010435297
Series, distributions, holdings and documents refresh daily.
rebalix.com/en/etf/FR0010435297
Series, distributions, holdings and documents refresh daily.
Sheet produced on 5 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.
Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.
Rebalix · 2820 · FR00104352972